8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Apr 9, 2026·SEC
Material company update
Apr 3, 2026·SEC
Definitive Healthcare Corp.(DH)Earnings, Financials & Key Ratios
DH•NASDAQ
$0.63
Price updated Jun 25, 2026
AboutDefinitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.Show more
- Revenue$242M-4.2%
- EBITDA$15M+102.3%
- Net Income-$139M+66.4%
- EPS (Diluted)-1.30+63.3%
- Gross Margin75.88%-3.1%
- EBITDA Margin6.31%+102.4%
- Operating Margin-8.52%+97.0%
- Net Margin-57.52%+64.9%
- ROE-28.18%+38.4%
DH Price & Volume
Definitive Healthcare Corp. (DH) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Contraction Challenges Operational Profitability Outlook
Investment Thesis • Updated 2026Q1
VerdictNegative: The company's inability to achieve GAAP profitability
Growth:Contracting
Profitability:Negative
Financial Position:Healthy
Cash Flow:Mixed
Primary Risk:Persistent Revenue Contraction
"Definitive Healthcare faces a challenging fundamental outlook characterized by a sustained revenue decline, evidenced by a -5.5% year-over-year contraction in 2026Q1. The company struggles to convert its data infrastructure into consistent profitability, as evidenced by a -8.6% operating margin and a massive $918.1 million retained earnings deficit. While the $157.6 million cash position provides a near-term liquidity buffer, the aggressive downward adjustment of goodwill from $1.1 billion to $235.4 million suggests significant structural risks to the long-term growth narrative."
Verdict Logic
coupled with a persistent -57.52% net margin and ongoing revenue contraction, suggests that the current valuation of 0.29x P/S does not adequately compensate for the underlying operational risks.
DH Growth Metrics
Definitive Healthcare Corp. (DH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years15.34%
3 Years2.75%
TTM-3.89%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM66.66%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM63.08%
Return on Capital
10 Years-11.53%
5 Years-15.92%
3 Years-25.3%
Last Year-2.73%
DH Recent Earnings
Definitive Healthcare Corp. (DH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 26, 2026Metric
Actual
Est
EPS
$0.06+0.0%
$0.06
Rev
$62M+3.2%
$60M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.07+16.7%
$0.06
Rev
$60M+0.8%
$60M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.07+40.0%
$0.05
Rev
$61M+2.6%
$59M
Q2 2025
May 8, 2025Metric
Actual
Est
EPS
$0.05+150.0%
$0.02
Rev
$59M+1.7%
$58M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.06vs $0.06+0.0% | $62Mvs $60M+3.2% |
| Q4 2025 | Nov 6, 2025 | $0.07vs $0.06+16.7% | $60Mvs $60M+0.8% |
| Q3 2025 | Aug 7, 2025 | $0.07vs $0.05+40.0% | $61Mvs $59M+2.6% |
| Q2 2025 | May 8, 2025 | $0.05vs $0.02+150.0% | $59Mvs $58M+1.7% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Definitive Healthcare Corp. (DH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.63 | $66.27M | -0.48 | -4.24% | -57.52% | -28.18% | 4.7% | |
| $158.08 | $25.68B | 29.06 | 16.34% | 28.37% | 13.36% | — | |
| $70.83 | $4.22B | 33.25 | 11.66% | 9.03% | 8.95% | — | |
| $19.85 | $3.71B | 20.26 | 13.05% | 30.4% | 19.36% | — | |
| $1.77 | $130.79M | -0.69 | 1.48% | -87.69% | -99.78% | — | |
| $28.26 | $2.34B | 128.45 | -10.86% | -2.42% | -1.59% | — |
Compare DH vs Peers
Definitive Healthcare Corp. (DH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DH SEC Filings & Documents
Definitive Healthcare Corp. (DH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when DH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DH Frequently Asked Questions
Definitive Healthcare Corp. (DH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Definitive Healthcare Corp.'s revenue?
Definitive Healthcare Corp. (DH) reported $238.3M in revenue for fiscal year 2025. This represents a 179% increase from $85.5M in 2019.
How fast is Definitive Healthcare Corp. growing?
Definitive Healthcare Corp. (DH) saw revenue decline by 4.2% over the past year.
Is DH profitable?
Definitive Healthcare Corp. (DH) reported a net loss of $170.3M for fiscal year 2025.
Dividend & Returns
Does DH pay dividends?
Yes, Definitive Healthcare Corp. (DH) pays a dividend with a yield of 4.70%. This makes it attractive for income-focused investors.
What is DH's return on equity?
Definitive Healthcare Corp. (DH) has a return on equity (ROE) of -28.2%. Negative ROE indicates the company is unprofitable.
What is Definitive Healthcare Corp.'s free cash flow?
Definitive Healthcare Corp. (DH) generated $37.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.